Penicillin, the world’s first antibiotic, transformed medicine in the early 1940s. Yet, in the beginning, production was so costly that only small batches could be made. Albert Alexander, the first patient treated with penicillin, died from its insufficient quantity.
During and after World War II, production methods improved, sparking a medical revolution. Today, many are hoping for a similar breakthrough with sickle cell disease. Gene therapies offer a promising solution, but several significant obstacles prevent treatment access.